文献速递乳腺MR

比较多种多b值扩散MRI模型预测乳腺癌新辅助化疗后病理完全缓解

Comparing Multi-b-Value Diffusion MRI Models for Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
PubMed 文献 · Radiology · 2025-01-01

前瞻性纳入2021年2月至2023年6月接受6或8周期新辅助化疗的连续乳腺癌女性,在新辅助化疗前及第2、4、6周期后行IVIM和DKI成像,比较纵向扩散参数预测病理完全缓解的能力。160例中36例达病理完全缓解;化疗早期(T2)整合临床病理与DKI参数的模型AUC为0.90,优于临床病理模型(AUC 0.79)和临床病理-IVIM模型(AUC 0.84)。

要点

  • 化疗早期(T2)DKI参数Dapp和表观峰度系数升高与新辅助化疗后病理完全缓解几率升高相关。
  • 整合临床病理与DKI参数的模型预测病理完全缓解AUC达0.90,优于临床病理模型和临床病理-IVIM模型。
  • ADC、组织扩散系数和非高斯ADC在病理完全缓解组与非病理完全缓解组间差异有统计学意义。

核心结论

  • 联合临床病理变量与化疗早期DKI参数的模型在预测乳腺癌新辅助化疗后病理完全缓解方面表现出色。

研究设计与样本

  • 前瞻性研究,纳入2021年2月至2023年6月接受6或8周期新辅助化疗的连续乳腺癌女性160例,化疗前(T1)及第2、4、6周期后(T2、T3、T4)行IVIM和DKI成像,以病理完全缓解为参考标准。

诊断标准与关键数值

  • T2时孕激素受体阳性与病理完全缓解几率降低相关(OR 0.10,95%CI 0.02–0.48,P=0.004)。
  • T2时人表皮生长因子受体2阳性(OR 4.51,95%CI 1.64–12.45,P=0.004)、较高Dapp(OR 8.44,95%CI 3.28–21.72,P<0.001)和较高表观峰度系数(OR 7.69,95%CI 3.03–19.53,P<0.001)与病理完全缓解几率升高相关。
  • 整合上述参数的临床病理-DKI模型预测病理完全缓解AUC为0.90(95%CI 0.84–0.94),优于临床病理模型(AUC 0.79,95%CI 0.72–0.85,P<0.001)和临床病理-IVIM模型(AUC 0.84,95%CI 0.77–0.89,P=0.04)。
  • ADC、组织扩散系数和非高斯ADC在病理完全缓解组与非病理完全缓解组间差异有统计学意义(P分别为0.04、0.02和0.01)。

临床应用与阅片要点

  • 作者认为,联合临床病理变量与化疗早期DKI参数的模型在预测乳腺癌新辅助化疗后病理完全缓解方面表现出色。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Multi-b-value diffusion MRI models have been used to predict pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) for breast cancer. However, there is a lack of longitudinal comparative research. Purpose To compare the performance of various diffusion MRI-derived longitudinal parameters during NAC for prediction of pCR in breast cancer. Materials and Methods This prospective study included consecutive women with breast cancer enrolled between February 2021 and June 2023 and treated with six or eight cycles of NAC. Each woman underwent intravoxel incoherent motion (IVIM) imaging and diffusion kurtosis imaging (DKI) before NAC (time point T1) and after two, four, and six cycles of NAC (T2, T3, and T4, respectively). The apparent diffusion coefficient (ADC) and IVIM and DKI parameters were compared using repeated-measures analysis of variance. Backward stepwise multivariable logistic regression analysis was used to identify parameters associated with pCR. Model performance was assessed using the area under the receiver operating characteristic curve (AUC) and was compared using the DeLong test. Results Among 160 women (mean age, 49.73 years ± 8.39 [SD]), 36 had pCR. ADC, tissue diffusion coefficient, and non-Gaussian ADC (Dapp) demonstrated significant differences between the pCR group and non-pCR group (P = .04, .02, and .01, respectively). At T2, progesterone receptor positivity (odds ratio [OR], 0.10 [95% CI: 0.02, 0.48]; P = .004) was associated with lower odds of pCR, while human epidermal growth factor receptor 2 positivity (OR, 4.51 [95% CI: 1.64, 12.45]; P = .004), higher Dapp (OR, 8.44 [95% CI: 3.28, 21.72]; P < .001), and higher apparent kurtosis coefficient (OR, 7.69 [95% CI: 3.03, 19.53]; P < .001) were associated with higher odds of pCR. The clinicopathologic-DKI model integrating these parameters exhibited an AUC of 0.90 (95% CI: 0.84, 0.94) in predicting pCR, outperforming the clinicopathologic model (AUC, 0.79 [95% CI: 0.72, 0.85]; P < .001) and clinicopathologic-IVIM model (AUC, 0.84 [95% CI: 0.77, 0.89]; P = .04). Conclusion A model combining clinicopathologic variables and DKI parameters after early NAC showed excellent performance in predicting pCR to NAC for breast cancer. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Thakur and Bitencourt in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Gong X, Wang X, Wang L, et al. Comparing Multi-b-Value Diffusion MRI Models for Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer. Radiology. 2025. PMID: 40693938. doi:10.1148/radiol.242969

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。